can glp 1 cause weight gain Glucagon-like peptide-1 receptor agonists and muscle mass effects GLP1 Receptor Agonists—Effects beyond Obesity

Gilead Sciences licensed an experimental, IL-12-targeted cancer drug from Xilo Therapeutics

Although this class of drugs, called glucagon-like peptide-1 or GLP-1, have been around for more than 17 years, with the first one, Byetta, approved in 2005, it is only recently that the class has made a big name for itself with the introduction of the popular once-weekly diabetic drug, Ozempic , and the equally popular obesity drug, Wegovy (the same drug as Ozempic but with a different dose)

Their energy-enhancing abilities work throughout the body, essentially charging up every body cell to function at optimal capacity

Serum peak is faster than IM, and B12 can be combined with hydration (saline), B-complex, vitamin C, magnesium, and other ingredients in the same bag

These metabolic improvements can have cascading effects on other hormone systems disrupted by insulin resistance, including sex hormones and inflammatory mediators